Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT05979909 2023-08-07

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

Phase 1 Not yet recruiting

40 enrolled

Genitourinary

Urothelial Carcinoma Ureter

NCT05698238 2023-03-15

CAMP1

Phase 1 Not yet recruiting

50 enrolled

BreastGenitourinaryHead & NeckOther solid neoplasmThoracic

Clear-cell metastatic renal cell carcinoma, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

JL19001-NMIBC

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

CALySSEY

Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer

Lutécio

PERSEVERANCE

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

A Study of DXC014 in Patients With Advanced Solid Tumors.

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

LumOnate

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

CAMP1